US · HELE · HOUSEHOLD & PERSONAL PRODUCTS
Helen of Troy Limited (HELE) intrinsic value and stock valuation
$34.44as of 2026-11-21 · Mkt cap 688.51M
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
Helen of Troy Limited DCF and intrinsic value
InvestorsCraft values HELE with the Chepakovich two-stage DCF model — currently rated strongly undervalued. How the model works · Run your own DCF prefilled from HELE’s statements →
Helen of Troy Limited Graham Number
The Graham Number is not defined for negative earnings or book value. Guide · Calculator →
How the business is doing
Fiscal 2012–2026, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $1.79B | $1.91B | $2.01B | $2.07B | $2.22B |
| Operating income | $106.8M | $142.8M | $260.6M | $211.8M | $272.6M |
| Net income | -$-898.98M | $123.8M | $168.6M | $143.3M | $223.8M |
| EPSd | -$-39.09M | $5.36M | $7.03M | $5.95M | $9.17M |
| Operating cash flow | $171.1M | $113.2M | $306.1M | $208.2M | $140.8M |
| Capital expenditure | -$-39.23M | -$-30.07M | -$-36.64M | -$-174.86M | -$-78.04M |
| Free cash flow | $131.9M | $83.1M | $269.4M | $33.4M | $62.8M |
| Total assets | $2.12B | $3.13B | $2.84B | $2.91B | $2.82B |
| Total debt | $833.7M | $956.8M | $702.9M | $977.1M | $857M |
| Net debt | $814.8M | $938M | $684.4M | $948M | $823.6M |
| Total equity | $798.2M | $1.68B | $1.64B | $1.49B | $1.33B |
| Cash and short-term investments | $18.9M | $18.9M | $18.5M | $29.1M | $33.4M |
Income statement
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $1.79B | $1.91B | $2.01B | $2.07B | $2.22B |
| Cost of revenue | $970.6M | $993.3M | $1.06B | $1.17B | $1.27B |
| Gross profit | $815.7M | $914.4M | $948.7M | $899.4M | $953.2M |
| Research and development expenses | $54M | $53.9M | $56.5M | $47.8M | $54M |
| Selling, general and administrative expenses | $708.9M | $622.7M | $621.7M | $595.9M | $611M |
| Other expenses | -$-54M | $95.1M | $9.84M | $43.9M | $15.6M |
| Operating expenses | $708.9M | $771.7M | $688.1M | $687.6M | $680.6M |
| Cost and expenses | $1.68B | $1.76B | $1.74B | $1.86B | $1.95B |
| Interest income | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest expense | $57.7M | $51.9M | $53.1M | $40.8M | $12.8M |
| Depreciation and amortization | $53.3M | $55.1M | $51.5M | $44.7M | $35.8M |
| Ebitda | -$-727.8M | $268.6M | $301.3M | $286.9M | $310.9M |
| Operating income | $106.8M | $142.8M | $260.6M | $211.8M | $272.6M |
| Total other income/expenses, net | -$-945.62M | -$-51.08M | -$-51.55M | -$-40.5M | -$-12.58M |
| Income before tax | -$-838.84M | $91.7M | $209M | $171.3M | $260M |
| Income tax expense | $60.1M | -$-32.09M | $40.5M | $28M | $36.2M |
| Net income | -$-898.98M | $123.8M | $168.6M | $143.3M | $223.8M |
| Weighted average shares outstanding | $23M | $23M | $24M | $24.1M | $24.4M |
| Weighted average diluted shares outstanding | $23M | $23.1M | $24M | $24.1M | $24.4M |
Balance sheet
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $18.9M | $18.9M | $18.5M | $29.1M | $33.4M |
| Net receivables | $366.7M | $434.1M | $402.4M | $382.8M | $463.1M |
| Inventory | $455.8M | $452.6M | $396M | $455.5M | $558M |
| Total current assets | $865.5M | $931.7M | $843.9M | $892M | $1.08B |
| Property, plant and equipment, net | $357.4M | $365.1M | $372.6M | $390.5M | $243.1M |
| Goodwill and intangible assets | $845.1M | $1.75B | $1.6B | $1.62B | $1.49B |
| Long-term investments | $0.00 | $300K | $1.19M | $1.82M | $2.92M |
| Total non-current assets | $1.25B | $2.2B | $1.99B | $2.02B | $1.74B |
| Total assets | $2.12B | $3.13B | $2.84B | $2.91B | $2.82B |
| Accounts payable | $256.4M | $269.4M | $245.4M | $190.6M | $308.2M |
| Short-term debt | $25M | $9.38M | $6.25M | $6.06M | $1.88M |
| Deferred revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total current liabilities | $505M | $466.3M | $450.8M | $412.2M | $602.7M |
| Long-term debt | $808.7M | $947.5M | $696.7M | $971M | $855.1M |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current liabilities | $812.4M | $982.4M | $750.4M | $1.01B | $893.4M |
| Capital lease obligations | $52.9M | $40M | $37.3M | $42.7M | $43.7M |
| Total liabilities | $1.32B | $1.45B | $1.2B | $1.42B | $1.5B |
| Common stock | $2.31M | $2.29M | $2.38M | $2.4M | $2.38M |
| Retained earnings | $412.8M | $1.31B | $1.28B | $1.16B | $1.02B |
| Accumulated other comprehensive income (loss) | -$-1.88M | $2.28M | $2.1M | $4.95M | $200K |
| Total equity | $798.2M | $1.68B | $1.64B | $1.49B | $1.33B |
| Total investments | $0.00 | $300K | $1.19M | $1.82M | $2.92M |
| Total debt | $833.7M | $956.8M | $702.9M | $977.1M | $857M |
| Net debt | $814.8M | $938M | $684.4M | $948M | $823.6M |
Cash flow statement
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Net income | -$-898.98M | $123.8M | $168.6M | $143.3M | $223.8M |
| Depreciation and amortization | $53.3M | $55.1M | $51.5M | $44.7M | $35.8M |
| Stock-based compensation | $0.00 | $21.4M | $33.9M | $26.8M | $34.6M |
| Change in working capital | $64.1M | -$-74.62M | $53.5M | -$-15.57M | -$-152.64M |
| Accounts receivable | $68M | -$-23.08M | -$-18.67M | $83.6M | -$-66.83M |
| Inventory | -$-3.2M | -$-40.6M | $58.2M | $110.3M | -$-45.91M |
| Accounts payable | -$-16.45M | $20.5M | $54.4M | -$-115.93M | -$-43.74M |
| Net cash provided by operating activities | $171.1M | $113.2M | $306.1M | $208.2M | $140.8M |
| Investments in property, plant and equipment | -$-39.23M | -$-30.07M | -$-36.64M | -$-174.86M | -$-78.04M |
| Acquisitions, net | $4.23M | -$-229.25M | $1.62M | -$-144.54M | -$-366.18M |
| Net cash used for investing activities | -$-34.43M | -$-263.09M | $5.45M | -$-319.33M | -$-438.91M |
| Common stock issued | $2.92M | $3.88M | $4.24M | $5.07M | $5.96M |
| Common stock repurchased | -$-1.92M | -$-103.19M | -$-55.22M | -$-18.36M | -$-188.2M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net cash used for financing activities | -$-136.69M | $150.3M | -$-322.09M | $106.8M | $286.4M |
| Net change in cash | $20K | $370K | -$-10.57M | -$-4.31M | -$-11.74M |
| Cash at end of period | $18.9M | $18.9M | $18.5M | $29.1M | $33.4M |
| Operating cash flow | $171.1M | $113.2M | $306.1M | $208.2M | $140.8M |
| Capital expenditure | -$-39.23M | -$-30.07M | -$-36.64M | -$-174.86M | -$-78.04M |
| Free cash flow | $131.9M | $83.1M | $269.4M | $33.4M | $62.8M |
Line items
Line items
Line items
About Helen of Troy Limited
Helen of Troy Limited is a global consumer products enterprise that markets a diverse array of goods across the United States, Canada, Europe, the Middle East, Africa, the Asia Pacific region, and Latin America. The company's operations are structured into three primary divisions: Home & Outdoor, Health & Wellness, and Beauty. The Home & Outdoor segment provides a variety of household essentials, including kitchen tools, storage and organization solutions, cleaning items, baby feeding and nursery products, insulated drinkware and food containers, and technical outdoor gear like backpacks and luggage. Within the Health & Wellness segment, offerings include health monitoring devices such as thermometers and blood pressure monitors, air quality appliances like purifiers, heaters, and humidifiers, and water purification systems. The Beauty division focuses on hair care, supplying grooming brushes, styling tools, decorative accessories, and a range of shampoos, conditioners, and styling products. Helen of Troy distributes its products through an extensive network that encompasses mass merchandisers, drugstore chains, warehouse clubs, home improvement centers, grocery stores, specialty retailers, beauty supply outlets, e-commerce platforms, wholesalers, and various distributors, in addition to direct-to-consumer sales. Notable brands under its umbrella include OXO, Hydro Flask, Osprey, PUR, Honeywell, Braun, Vicks, Drybar, Hot Tools, Revlon, and Bed Head. Incorporated in 1968, the company is headquartered in El Paso, Texas.
- CEO
- George Scott Uzzell
- Employees
- 1.85K
- Beta
- 1.31
Included in
Explore
Frequently asked questions
What is the intrinsic value of Helen of Troy Limited (HELE)?
Helen of Troy Limited (HELE) is currently strongly undervalued based on the InvestorsCraft IC model — IC value is more than 50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is HELE undervalued?
HELE trades at a price of $34.44 (Nov 21, 2026): strongly undervalued — IC value is more than 50% above the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.